Search research articles
Contact Us
Filters
Showing results (111-120 of 151) with videos related to
Page
of 16
Sort By:
Bone Marrow Transplantation
|
September 1, 1991
Early haemostatic modifications following cryopreserved graft infusion
A M Vannucchi, G Longo, A Bosi, et al.
Thrombosis Research
|
March 15, 1992
Pharmacokinetics of two pasteurized factor VIII concentrates by different and multicenter assays of factor VIII activity
A Messori, M Morfini, M Blomback, et al.
Blood
|
February 1, 1990
Recurrent mutations and three novel rearrangements in the factor VIII gene of hemophilia A patients of Italian descent
L Casula, S Murru, M Pecorara, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
April 20, 2010
The need for speed in the management of haemophilia patients with inhibitors
S Z Salek, G M Benson, I Elezović, et al.
Blood
|
May 15, 1997
A multicenter controlled, randomized, open trial of interferon alpha2b treatment of anti-human immunodeficiency virus-negative hemophilic patients with chronic hepatitis C. Hepatitis Study Group of the Association of Italian Hemophilia Centers
M G Rumi, E Santagostino, M Morfini, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
March 19, 2016
Correlation between FIX genotype and pharmacokinetics of Nonacog alpha according to a multicentre Italian study
M Morfini, A Dragani, E Paladino, et al.
American Journal of Hematology
|
March 1, 1989
Evaluation of factor VIII pharmacokinetics in hemophilia-A subjects undergoing surgery and description of a nomogram for dosing calculations
G Longo, A Messori, M Morfini, et al.
Journal of Medical Virology
|
February 1, 1992
Low risk of transmission of the human immunodeficiency virus by a solvent-detergent-treated commercial factor VIII concentrate
T Di Paolantonio, G Mariani, A Ghirardini, et al.
Vox Sanguinis
|
January 1, 1994
Prevalence of infection with the hepatitis C virus among Italian hemophiliacs before and after the introduction of virally inactivated clotting factor concentrates: a retrospective evaluation
M Morfini, P M Mannucci, N Ciavarella, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
February 8, 2013
Novel coagulation factor concentrates: issues relating to their clinical implementation and pharmacokinetic assessment for optimal prophylaxis in haemophilia patients
R Ljung, G Auerswald, G Benson, et al.
Page
of 16
Search research articles
Search
Showing results (111-120 of 151) with videos related to
Sort By:
Page
of 16
Bone Marrow Transplantation
|
September 1, 1991
Early haemostatic modifications following cryopreserved graft infusion
A M Vannucchi, G Longo, A Bosi, et al.
Thrombosis Research
|
March 15, 1992
Pharmacokinetics of two pasteurized factor VIII concentrates by different and multicenter assays of factor VIII activity
A Messori, M Morfini, M Blomback, et al.
Blood
|
February 1, 1990
Recurrent mutations and three novel rearrangements in the factor VIII gene of hemophilia A patients of Italian descent
L Casula, S Murru, M Pecorara, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
April 20, 2010
The need for speed in the management of haemophilia patients with inhibitors
S Z Salek, G M Benson, I Elezović, et al.
Blood
|
May 15, 1997
A multicenter controlled, randomized, open trial of interferon alpha2b treatment of anti-human immunodeficiency virus-negative hemophilic patients with chronic hepatitis C. Hepatitis Study Group of the Association of Italian Hemophilia Centers
M G Rumi, E Santagostino, M Morfini, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
March 19, 2016
Correlation between FIX genotype and pharmacokinetics of Nonacog alpha according to a multicentre Italian study
M Morfini, A Dragani, E Paladino, et al.
American Journal of Hematology
|
March 1, 1989
Evaluation of factor VIII pharmacokinetics in hemophilia-A subjects undergoing surgery and description of a nomogram for dosing calculations
G Longo, A Messori, M Morfini, et al.
Journal of Medical Virology
|
February 1, 1992
Low risk of transmission of the human immunodeficiency virus by a solvent-detergent-treated commercial factor VIII concentrate
T Di Paolantonio, G Mariani, A Ghirardini, et al.
Vox Sanguinis
|
January 1, 1994
Prevalence of infection with the hepatitis C virus among Italian hemophiliacs before and after the introduction of virally inactivated clotting factor concentrates: a retrospective evaluation
M Morfini, P M Mannucci, N Ciavarella, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
February 8, 2013
Novel coagulation factor concentrates: issues relating to their clinical implementation and pharmacokinetic assessment for optimal prophylaxis in haemophilia patients
R Ljung, G Auerswald, G Benson, et al.
Page
of 16